首页> 外文期刊>Scientific reports. >A De Novo Nonsense Mutation in MAGEL2 in a Patient Initially Diagnosed as Opitz-C: Similarities Between Schaaf-Yang and Opitz-C Syndromes
【24h】

A De Novo Nonsense Mutation in MAGEL2 in a Patient Initially Diagnosed as Opitz-C: Similarities Between Schaaf-Yang and Opitz-C Syndromes

机译:在最初被诊断为OPITZ-C的患者中的魔法中的DE Novo非义突变突变:Schaaf-yang和Opitz-C综合征之间的相似性

获取原文
           

摘要

Opitz trigonocephaly C syndrome (OTCS) is a rare genetic disorder characterized by craniofacial anomalies, variable intellectual and psychomotor disability, and variable cardiac defects with a high mortality rate. Different patterns of inheritance and genetic heterogeneity are known in this syndrome. Whole exome and genome sequencing of a 19-year-old girl (P7), initially diagnosed with OTCS, revealed a de novo nonsense mutation, p.Q638*, in the MAGEL2 gene. MAGEL2 is an imprinted, maternally silenced, gene located at 15q11-13, within the Prader-Willi region. Patient P7 carried the mutation in the paternal chromosome. Recently, mutations in MAGEL2 have been described in Schaaf-Yang syndrome (SHFYNG) and in severe arthrogryposis. Patient P7 bears resemblances with SHFYNG cases but has other findings not described in this syndrome and common in OTCS. We sequenced MAGEL2 in nine additional OTCS patients and no mutations were found. This study provides the first clear molecular genetic basis for an OTCS case, indicates that there is overlap between OTCS and SHFYNG syndromes, and confirms that OTCS is genetically heterogeneous. Genes encoding MAGEL2 partners, either in the retrograde transport or in the ubiquitination-deubiquitination complexes, are promising candidates as OTCS disease-causing genes.
机译:Opitz Trigonocephycy C综合征(OTCS)是一种罕见的遗传疾病,其特征是颅面异常,可变智力和精神运动残疾,以及具有高死亡率的可变心脏缺陷。在该综合征中已知不同的遗传和遗传异质性模式。一位19岁女孩(P7)的全外壳和基因组测序最初被诊断出患有OTCS,揭示了Magel2基因的De Novo非义突变,P.Q638 *。 Magel2是位于Prader-Willi地区15季度的印记,母系沉默的基因,位于Prader-Willi地区。患者P7携带父母染色体中的突变。最近,Magel2中的突变已在Schaaf-yang综合征(Shfyng)和严重的腺血症中描述。患者P7与SHFYNG病例相似,但在这种综合征中没有描述其他发现,并且在OTCS中常见。我们在九个额外OTCS患者中测序Magel2,没有发现突变。本研究为OTCS案例提供了第一透明分子遗传基础,表明OTC和SHFYNG综合征之间存在重叠,并确认OTC是遗传异质的。编码Magel2合作伙伴的基因,无论是逆行传输还是泛素脱氢化络合物,都是候选人的候选者,作为疾病导致基因。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号